Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Complement C4 Antibody Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...
Figure 1: Complement activation is involved in tumor growth. Because the formation of C3 convertase is the point in the complement cascade at which the three known pathways of complement activation ...
4DMT acquires all world-wide rights to short-form human complement factor H (sCFH) from Aevitas Therapeutics, Inc.; technology invented at University of Pennsylvania Announces sCFH as payload for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results